Cite
Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort.
MLA
Basch, Ethan, et al. “Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-Resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort.” European Urology, vol. 67, no. 2, Feb. 2015, pp. 310–18. EBSCOhost, https://doi.org/10.1016/j.eururo.2014.02.013.
APA
Basch, E., Autio, K. A., Smith, M. R., Bennett, A. V., Weitzman, A. L., Scheffold, C., Sweeney, C., Rathkopf, D. E., Smith, D. C., George, D. J., Higano, C. S., Harzstark, A. L., Sartor, A. O., Gordon, M. S., Vogelzang, N. J., de Bono, J. S., Haas, N. B., Corn, P. G., Schimmoller, F., & Scher, H. I. (2015). Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort. European Urology, 67(2), 310–318. https://doi.org/10.1016/j.eururo.2014.02.013
Chicago
Basch, Ethan, Karen A. Autio, Matthew R. Smith, Antonia V. Bennett, Aaron L. Weitzman, Christian Scheffold, Christopher Sweeney, et al. 2015. “Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-Resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort.” European Urology 67 (2): 310–18. doi:10.1016/j.eururo.2014.02.013.